Bank of Nova Scotia Makes New $5.25 Million Investment in Encompass Health Corporation $EHC

Bank of Nova Scotia purchased a new stake in Encompass Health Corporation (NYSE:EHC - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 51,926 shares of the company's stock, valued at approximately $5,249,000. Bank of Nova Scotia owned approximately 0.05% of Encompass Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. EP Wealth Advisors LLC lifted its position in Encompass Health by 2.4% in the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company's stock valued at $453,000 after acquiring an additional 88 shares in the last quarter. Gamco Investors INC. ET AL increased its holdings in Encompass Health by 2.0% during the 1st quarter. Gamco Investors INC. ET AL now owns 4,813 shares of the company's stock worth $466,000 after purchasing an additional 94 shares in the last quarter. Gibson Capital LLC raised its stake in shares of Encompass Health by 4.3% in the 1st quarter. Gibson Capital LLC now owns 2,431 shares of the company's stock valued at $235,000 after purchasing an additional 101 shares during the period. Leuthold Group LLC lifted its holdings in shares of Encompass Health by 0.3% in the fourth quarter. Leuthold Group LLC now owns 31,168 shares of the company's stock valued at $3,308,000 after purchasing an additional 104 shares in the last quarter. Finally, Covestor Ltd lifted its holdings in shares of Encompass Health by 24.4% in the fourth quarter. Covestor Ltd now owns 540 shares of the company's stock valued at $57,000 after purchasing an additional 106 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Stock Down 0.6%

EHC stock opened at $120.18 on Wednesday. The company has a market cap of $11.86 billion, a price-to-earnings ratio of 19.57, a P/E/G ratio of 2.45 and a beta of 0.72. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The business has a 50 day moving average price of $111.85 and a two-hundred day moving average price of $106.83. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the prior year, the firm posted $1.40 EPS. The firm's revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Analysts anticipate that Encompass Health Corporation will post 6.09 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.21 dividend. This is a boost from Encompass Health's previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health's payout ratio is 12.38%.

Wall Street Analyst Weigh In

EHC has been the subject of a number of research reports. Weiss Ratings upgraded Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, August 12th. Wall Street Zen upgraded Encompass Health from a "hold" rating to a "buy" rating in a research note on Sunday, August 16th. Barclays upped their price target on Encompass Health from $140.00 to $144.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a report on Friday, May 22nd. Finally, TD Cowen boosted their price objective on shares of Encompass Health from $125.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $148.71.

Insider Activity

In other news, CEO Mark J. Tarr sold 173,148 shares of the company's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total value of $21,724,879.56. Following the sale, the chief executive officer directly owned 267,814 shares of the company's stock, valued at approximately $33,602,622.58. This represents a 39.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP John Patrick Darby sold 8,906 shares of the firm's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the completion of the sale, the executive vice president owned 75,041 shares of the company's stock, valued at $9,451,413.95. This trade represents a 10.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.80% of the stock is owned by insiders.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source